Publications: Dr Emma Magavern
Magavern EF, Caulfield MJ
(
2023
)
.
Equal access to pharmacogenomics testing: The ethical imperative for population-wide access in the UK NHS
.
Br J Clin Pharmacol
Adeyeye E, Maniero C, Magavern EF, Ferner RE, McGettigan P
(
2022
)
.
Prescribing direct-acting oral anticoagulants – Mind the evidence gap
.
British Journal of Clinical Pharmacology
vol.
88
,
(
11
)
4724
-
4731
.
Turner RM, Magavern EF, Pirmohamed M
(
2022
)
.
Pharmacogenomics: Relevance and opportunities for clinical pharmacology
.
British Journal of Clinical Pharmacology
vol.
88
,
(
9
)
3943
-
3946
.
Finocchiaro G, Magavern EF, Georgioupoulos G, Maurizi N, Sinagra G, Carr-White G, Pantazis A, Olivotto I
(
2022
)
.
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era
.
Heart Failure Reviews
vol.
27
,
(
5
)
1749
-
1759
.
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN et al.
(
2022
)
.
Challenges in cardiovascular pharmacogenomics implementation: A viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
.
European Heart Journal - Cardiovascular Pharmacotherapy
vol.
8
,
(
1
)
100
-
103
.
Magavern EF, Piasecki J, Cohen A, Cremers S
(
2022
)
.
Ethics in clinical pharmacology: Facilitating public trust
.
British Journal of Clinical Pharmacology
vol.
88
,
(
1
)
5
-
6
.
Magavern EF, Gurdasani D, Ng FL, Lee SSJ
(
2022
)
.
Health equality, race and pharmacogenomics
.
British Journal of Clinical Pharmacology
vol.
88
,
(
1
)
27
-
33
.
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN et al.
(
2022
)
.
The role of pharmacogenomics in contemporary cardiovascular therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
.
European Heart Journal - Cardiovascular Pharmacotherapy
vol.
8
,
(
1
)
85
-
99
.
Magavern EF, Daly AK, Gilchrist A, Hughes DA
(
2021
)
.
Pharmacogenomics spotlight commentary: From the United Kingdom to global populations
.
British Journal of Clinical Pharmacology
vol.
87
,
(
12
)
4546
-
4548
.
Magavern EF, Cremers S
(
2021
)
.
Introduction to clinical pharmacology at large
.
British Journal of Clinical Pharmacology
vol.
87
,
(
8
)
3026
-
3027
.
Magavern EF, Kaski JC, Turner RM, Janmohamed A, Borry P, Pirmohamed M
(
2021
)
.
The Interface of Therapeutics and Genomics in Cardiovascular Medicine
.
Cardiovascular Drugs and Therapy
vol.
35
,
(
3
)
663
-
676
.
Abaleke E, Abbas M, Abbasi S, Abbott A, Abdelaziz A, Abdelbadiee S, Abdelfattah M, Abdul B et al.
(
2021
)
.
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
.
The Lancet
vol.
397
,
(
10274
)
605
-
612
.
Magavern EF, Warren HR, Ng FL, Cabrera CP, Munroe PB, Caulfield MJ
(
2021
)
.
An Academic Clinician's Road Map to Hypertension Genomics: Recent Advances and Future Directions MMXX
.
Hypertension
vol.
77
,
(
2
)
284
-
295
.
Magavern E, Khong TK
(
2021
)
.
Effect of dapagliflozin on cardiovascular events in patients with type 2 diabetes
.
Drug and Therapeutics Bulletin
vol.
59
,
(
2
)
22
-
23
.
Burrai F, Magavern EF, Micheluzzi V, Magnaghi C, Apuzzo L, Brioni E
(
2020
)
.
Effectiveness of Music to Improve Anxiety in Hemodialysis Patients A Systematic Review and Meta-analysis
.
Holistic Nursing Practice
vol.
34
,
(
6
)
324
-
333
.
Burrai F, Mettifogo M, Micheluzzi V, Ferreira FE, Pinna L, Magavern EF
(
2020
)
.
Narrative-Based Practice
.
Holistic Nursing Practice
vol.
34
,
(
5
)
306
-
313
.